Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/18/2012US8268808 Carrageenan and carrageenan-containing products
09/18/2012US8268807 Compositions and method for the treatment of multiple myeloma
09/18/2012US8268806 Pharmaceutical compositions
09/18/2012US8268805 Use of ceramides for depigmenting the skin
09/18/2012US8268804 Minocycline oral dosage forms for the treatment of acne
09/18/2012US8268803 5, 6-ring annulated indole derivatives and use thereof
09/18/2012US8268802 Anti-proliferative compounds, compositions, and methods of use thereof
09/18/2012US8268800 Certain compounds, compositions and methods
09/18/2012US8268799 Compositions and methods for inhibiting expression of the HAMP gene
09/18/2012US8268792 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
09/18/2012US8268791 Alkylglycoside compositions for drug administration
09/18/2012US8268790 Dermatalogical formulations
09/18/2012US8268786 Anti-cancer tocotrienol analogues and associated methods
09/18/2012US8268785 Use of a Pde 5 inhibitor for treating and preventing hypopigmentary disorders
09/18/2012US8268774 Method for reducing pain
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity
09/18/2012US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
09/18/2012US8268381 Methods and systems for coating a medical device
09/18/2012US8268363 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto
09/18/2012US8268357 Processes for the preparation of lipophilic drug delivery vehicles
09/18/2012US8268356 Aqueous film coating solution, film coated granule and tablet using the same
09/18/2012US8268351 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings
09/18/2012US8268349 Solid pharmaceutical dosage form
09/18/2012US8268346 Methods of treating hot flashes with formulations for transdermal or transmucosal application
09/18/2012US8268343 Non-hormonal vaginal contraceptive
09/18/2012US8268339 Agrochemical formulations containing pyrrolidone alkylene oxides
09/18/2012US8268337 Nontoxic killer of E. coli and other problem microorganisms
09/18/2012US8268336 Compositions containing aromatic aldehydes and their use in treatments
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012US8268313 Methods for using inhibitors of vascular endothelial growth factor activity
09/18/2012US8268301 For drug delivery or biodrug delivery; acrylic type monomers; hydrolyzable group is hydrolyzable to an anionic center to provide a zwitterionic polymer having the anionic center covalently coupled to the cationic center through the second linker
09/18/2012US8268300 Material for aneurysm curing
09/18/2012US8268299 Self preserved aqueous pharmaceutical compositions
09/18/2012US8268292 Obovatol having anti-anxiety activity
09/18/2012US8268291 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
09/18/2012US8268240 Ciclesonide-containing sterile aqueous suspension
09/18/2012US8267982 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
09/18/2012CA2705729C Pyrazole derivatives as 5-lo inhibitors
09/18/2012CA2696613C Compositions and methods for modulating endophthalmitis using fluoroquinolones
09/18/2012CA2669913C Endoxifen methods and compositions
09/18/2012CA2647086C Identification of a jak2 mutation in polycythemia vera
09/18/2012CA2635664C Compositions and methods of sensitizing methicillin resistant staphylococcus aureus to oxacillin
09/18/2012CA2616589C Compositions for the reversible thioesterification of signaling proteins and methods of using same
09/18/2012CA2607907C Method for producing indole derivative having piperidine ring
09/18/2012CA2606521C Dihydropyridine derivatives
09/18/2012CA2588417C 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
09/18/2012CA2586664C Isoxazolic derivative to relieve neuropathic pain
09/18/2012CA2560669C Pyrrolidine-3,4-dicarboxamide derivatives
09/18/2012CA2554536C Crystalline forms of gaboxadol monohydrate or anhydrate
09/18/2012CA2549604C Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide
09/18/2012CA2549516C Percutaneous absorption-type pharmaceutical preparation
09/18/2012CA2546002C 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/18/2012CA2531832C Powdery formulations for inhalation, containing a novel anticholinergic agent
09/18/2012CA2529742C Composition of a vegf antagonist and an anti-proliferative agent
09/18/2012CA2528431C Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
09/18/2012CA2525486C Composition for lowering the internal lipid
09/18/2012CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
09/18/2012CA2519110C Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
09/18/2012CA2517120C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
09/18/2012CA2515259C Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
09/18/2012CA2511185C A physically and chemically stable nicotine-containing particulate material
09/18/2012CA2507002C Solid drug for oral use
09/18/2012CA2503729C Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
09/18/2012CA2501717C Use of epothilone derivatives for the treatment of hyperparathyroidism
09/18/2012CA2493604C Patch containing fentanyl for mucous membrane of oral cavity
09/18/2012CA2493165C Oral composition with enhanced organoleptic properties comprising an enzyme and cyclodextrin
09/18/2012CA2492855C Myocardial perfusion imaging using a2a receptor agonists
09/18/2012CA2492325C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
09/18/2012CA2490993C Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparations and uses thereof
09/18/2012CA2490986C Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
09/18/2012CA2480226C Stable pharmaceutical composition containing factor viii
09/18/2012CA2479659C Choline-silicic acid complex with osmolytes and divalent trace elements
09/18/2012CA2466935C Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same
09/18/2012CA2451133C Therapeutic agent for sepsis
09/18/2012CA2448647C Developmental animal model of temporal lobe epilepsy
09/18/2012CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
09/18/2012CA2405731C Compositions and methods for improving vascular health
09/18/2012CA2399310C The method of obtaining immunotropic antiviral preparation
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2378943C Super-active porcine growth hormone releasing hormone analog
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2273083C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/17/2012CA2734312A1 Methods and compositions for promoting the respiratory development of an infant
09/16/2012CA2734300A1 Heat assisted lidocaine and tetracaine for transdermal analgesia
09/13/2012WO2012122542A2 Intelligent airfoil component surface imaging inspection
09/13/2012WO2012122524A1 Wound healant system and method of use
09/13/2012WO2012122515A1 Treatment of disorders with altered vascular barrier function
09/13/2012WO2012122493A1 Lipid based clopidogrel compositions, methods, and uses
09/13/2012WO2012122471A2 Compounds and methods of use in ablative radiotherapy
09/13/2012WO2012122456A2 Heavy-duty vehicle brake assembly with sealing interface
09/13/2012WO2012122452A1 2,4 substituted pyrimidinediamines for use in discoid lupus
09/13/2012WO2012122451A2 Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
09/13/2012WO2012122414A2 Linear dispensing system with universal escapement
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012122371A2 Radial flow immunoassay and methods of production and use thereof
09/13/2012WO2012122368A1 Deoxycytidine kinase binding compounds
1 ... 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 ... 7860